TREATMENT OF PRIMARY ADENOCARCINOMA OF THE CERVIX

Publisher Website
Google Scholar
Abstract
There is no definite evidence that adenocarcinoma of the cervix is more resistant than squamous cell carcinoma. The high incidence of positive specimens, in spite of the fact that radiation dosage was not changed and surgery was done at the proper time, can be explained on the basis of a different biologic response of the tumor which probably requires a longer period of time to disappear. The persistence of histologically detectable tumor in the cervix at the time of surgery does not seem to adversely affect the prognosis. Postirradiation hysterectomy does not modify the survival. The high incidence of complications following surgery performed in irradiated tissues contraindicates the procedure done in routine manner. Surgery should be considered only in those cases in which 2 months have elapsed since completion of therapy and which reveal clinical evidence of massive residual, still resect-able disease, and, of course, in the postirradiation recurrences. The results obtained by radiation therapy in adenocarcinoma and in squamous cell carcinoma of the cervix are statistically similar.

This publication has 1 reference indexed in Scilit: